Your browser doesn't support javascript.
loading
Disease Severity, Fever, Age, and Sex Correlate With SARS-CoV-2 Neutralizing Antibody Responses.
Schlickeiser, Stephan; Schwarz, Tatjana; Steiner, Sophie; Wittke, Kirsten; Al Besher, Nabeel; Meyer, Oliver; Kalus, Ulrich; Pruß, Axel; Kurth, Florian; Zoller, Thomas; Witzenrath, Martin; Sander, Leif Erik; Müller, Marcel A; Scheibenbogen, Carmen; Volk, Hans-Dieter; Drosten, Christian; Corman, Victor M; Hanitsch, Leif G.
Afiliação
  • Schlickeiser S; Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Schwarz T; Berlin Institute of Health Center for Regenerative Therapies (BCRT), Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Steiner S; Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Wittke K; Institute of Virology, Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, and German Centre for Infection Research (DZIF), Partner Site Charité, Berlin, Germany.
  • Al Besher N; Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Meyer O; Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Kalus U; Institute of Transfusion Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Pruß A; Institute of Transfusion Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Kurth F; Institute of Transfusion Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Zoller T; Institute of Transfusion Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Witzenrath M; Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Sander LE; Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
  • Müller MA; Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Scheibenbogen C; Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Volk HD; German Center for Lung Research (DZL), Partner Site Charité, Berlin, Germany.
  • Drosten C; Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Corman VM; German Center for Lung Research (DZL), Partner Site Charité, Berlin, Germany.
  • Hanitsch LG; Institute of Virology, Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, and German Centre for Infection Research (DZIF), Partner Site Charité, Berlin, Germany.
Front Immunol ; 11: 628971, 2020.
Article em En | MEDLINE | ID: mdl-33584731

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doadores de Sangue / Anticorpos Neutralizantes / COVID-19 / Anticorpos Antivirais Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doadores de Sangue / Anticorpos Neutralizantes / COVID-19 / Anticorpos Antivirais Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article